ACSL3 and cancer: To assess whether LPIAT1 requires ACSL3-derived substrates to control cancer cell proliferation, we overexpressed LPIAT1 with a lentiviral construct in A549 and H358 cell lines and performed cell proliferation assays upon ACSL3 knockdown.